NAMP National Anti Malaria Program
Topics Discussed
Organisation & Implementation of National Anti Malaria Program in the District Techniques of blood examinations; Staining & Identification techniques Spraying techniques & Strategies Monitoring of the program
Organisation & Implementation
N A M P is a Cat II centrally sponsored Venture
50 : 50 cost sharing
Central --- Drugs, Insecticides / Larvicides, Technical assistance State
--- Operational costs including staff salary
RBM 98
NMCP 53 ---- NMEP 58 ---- UMS 71 ---- MPO 77 ---- MAP 95 ---- EMCP 97 ---- NAMP 99 Integration of the malaria maintenance phase under NMEP with the General Health Services --- Chadha Committee 63 Along with MPO 77,the MPW Scheme (Kartar Sing Committee) & VHG Scheme 77 took shape Carry out active & Passive Surveillance ; 1 H.I (Surveillance Inspector) for 4 MPW The PHC Medical Officers have a key role in the execution of the program In addition to the District Health Officer, the existing unit officers have been designated District Malaria Officers – entrusted with the operational & evaluation aspects of the program The DMO is assisted by Asst. Malaria Officers Lab services decentralised; Lab technicians posted at each PHC; come under the DMO
Malaria Trend across the centuries, in India
Six elements of Roll Back M a l a r i a 1. Evidence-based-decisions using surveillance, appropriate responses and building community awareness 2. Rapid diagnosis and treatment 3. Multiple prevention. Better multipronged protection using insecticide treated mosquito nets, environmental management to control mosquitoes and making pregnancy safer 4. Focussed research to develop new medicines, vaccines and insecticides and to help epidemiological and operational activities 5. Coordinated action for strengthening existing health services, policies and providing technical support. 6. Harmonised actions to build a dynamic global movement.
N A M P Control Strategies API >2
API<2 Focal Spraying
Spraying Entomological assessment Surveillance ( active & passive ) Treatment
Active surv once in 15 days
Surveillance ( active & passive ) Treatment Follow up Epidemiological Investigation
Treatment Presumptive Tab. Chloroquine 600 mg ( 10 mg/kg ) + Tab. Primaquine 15 mg ( 0.25 mg/kg ) Vivax
Radical
Tab. Chloroquine 600 mg ( 10 mg/kg ) + Tab. Primaquine 15 mg ( 0.25 mg/kg ) on day 1 Tab. Primaquine 15 mg on day 2, 3, 4 and 5 Falciparum Tab. Chloroquine 600 mg ( 10 mg/kg ) + Tab. Primaquine 45 mg ( 0.25 mg/kg )
MALARIA INCIDENCE IN RURAL AND URBAN AREAS OF TAMILNADU Year
State Cases
Rural Cases
Chennai Cases
Chennai %
Other UMS Cases
Other UMS %
1990
120029
48478
51272
42.7
20279
16.9
1991
144762
57403
67013
46.3
20346
14.1
1992
151633
52298
72314
47.7
27021
17.8
1993
148057
42908
76749
51.8
28400
19.2
1994
104964
39736
48352
46.1
16876
16.1
1995
92375
40739
41822
45.3
9814
10.6
1996
80586
27249
45930
57.0
7407
9.2
1997
72426
23429
41735
57.6
7262
10.0
1998
63915
16023
40475
63.3
7417
11.6
1999
56366
12141
38165
67.7
6060
10.8
2000
43053
7574
31861
74.0
3618
8.4
31551
5121
23652
75.0
2778
8.8
2002
34523
5490
27205
78.8
1828
5.3
2002 (Jan to Nov)
31385
5017
24725
78.8
1643
5.2
39423
11105
26429
67.0
1889
4.8
2001
2003(Jan to Nov)
The control strategies adopted by the TamilNadu Public Health dept : 1) Malaria case detection is being carried out by house to house visit by collection of blood smears from fever cases and giving treatment for those who are found positive for malaria. 2) Two rounds of residual insecticidal spray during transmission period using synthetic pyrethroid in malaria endemic areas. 3) Passive surveillance and anti-larval work in urban. 4) Creating awareness among the community for their participation. 5) Whenever imported cases recorded , the same is cross notified by the concerned Medical Officer to the respective Health Authorities of State for further remedial action at their end. 6) Mass and contact Blood survey are being carried out to prevent the occurrence of secondary cases. 7) Whenever necessary, focal spray is being carried out. Active surveillance has become a problem all over the country in the recent past. In Tamil Nadu, IEC activities have made a great impact on surveillance, that more number of cases are being identified under passive surveillance than Active surveillance. Geographical Information system (GIS) is being developed in Tamilnadu for carrying out epidemiological mapping of the villages and for identifying vulnerable areas and seasonal pattern of disease outbreak. www.tnhealth.org/dphpm/dbmal
Spraying techniques & Strategies
SPRAYING Rapidly reduce populations of flying insect pests and vectors ( A D U L T S ) Exacting, periodical & continuous efforts vital for the success of operations Space spray treatments
Outdoor
No Residual Effects Space spray equipment
Hand-carried Thermal fog / Cold fog
Vehicle-mounted Aircraft application
Residual Spray Treatments
Indoor
Residual Effects Sound knowledge on the Vector breeding sites, lifespan, feeding habits, seasonal trends (Ecology) essential for successful, cost-effective anti-adult spraying campaigns Dose and residual effect are important considerations in determining the number of spray rounds needed to protect a population during the whole, or only the peak, of the transmission season.
SPACE SPRAYS A space spray – technically a fog (sometimes referred to as an aerosol) – is a liquid insecticide dispersed into the air in the form of hundreds of millions of tiny droplets A very important characteristic of space sprays is the size of the droplets being Dispersed, since this determines the time that they remain in suspension in the air and their ability to penetrate into spaces that are not fully open. Sprays, measured by their volume median diameter (VMD), are divided in accordance with their droplet size into Coarse sprays
with a VMD over 400 µm
Fine sprays
with a VMD between 100 and 400 µm
Mists
with a VMD between 50 and 100 µm
Fogs or ultra-low volume (ULV) sprays
with a VMD below 50 µm
WHO Classification of Pesticides by Hazard (WHO/UNEP/ILO, 1994)
Class 1a
Extremely hazardous
Class 1b
Highly hazardous
Class 2
Moderately hazardous
Class 3
Slightly hazardous
UH
Unlikely to be hazardous
The technical products listed in Table 1 as recommended for malaria control belong to class II, with the exception of malathion and pyrimiphos-methyl, which belong to class III. In fact, all the formulations used, at the dilutions actually applied, belong to class III.
Techniques of blood examinations
MICROSCOPIC DIAGNOSIS Conventional light microscopy is the established method for the laboratory confirmation of malaria. Microscopy offers many advantages It is sensitive.
It is informative.
It is relatively inexpensive.
It is a general diagnostic technique that can be shared with other disease control programmes, such as those against tuberculosis or sexually transmitted diseases. It can provide a permanent record (the smears) of the diagnostic findings and be subject to quality control. Microscopy suffers from three main disadvantages It is labour-intensive and time-consuming, normally requiring at least 60 minutes from specimen collection to result. It is exacting and depends absolutely on good techniques, reagents, microscopes and, most importantly, well trained and well supervised technicians. There are often long delays in providing the microscopy results to the clinician, so that decisions on treatment are often taken without the benefit of the results.
Monitoring
Monitoring and evaluation Monitoring measures the implementation of the range of strategic activities
Monitoring, which is a continuous on-going activity allows step-by-step recording of the progress made by health programmes
Evaluation measures the extent to which the objectives are being reached Evaluation is concerned with impact indicators, which allow periodic assessment of the way in which strategies and implemented activities reach the planned objectives.
Parameters of Malaria Surveillance API
ABER
=
=
Confirmed cases during the Yr
X 1000
Population under surveillance # of slides examined
X 100
Population under surveillance
Index of Operational Efficiency
WHO – 1 % of Pop / month ; MPO – 10 % of Pop / Yr Vector Indices :
Monthly blood examn rates
1. Human Blood Index
Transmission season Non-transmission season (July – oct) 2. Sporozoite Rate
Active 2% 3. Mosq density ( # of mosq/man-hour-catch )
1% 4. Inoculation Rates
Passive as % of new OPD cases 20 % 5. Man biting Rate ( biting density – bites/day/person )
Annual Falciparum Incidence
15 %
pf proportion
Slide Positivity Rate Spleen Rate Slide Falciparum Rate
Measure of Endemicity of Malaria
Malaria Situation in Coimbatore district ( 1998 – 2002 )
Year
Total Population
Blood smears examined
Total +ve
pf
ABER
SPR
SFR
API
Death
Radical Rx given
1998
24,92,219
2,42,036
21
5
10.7
0.08
0.002
0.01
-
21
1999
25,14,963
2,42,984
125
54
9.51
0.05
0.02
0.05
-
91
2000
25,20,557
2,48,424
7
1
9.4
0.003
0.004
0.002
-
7
2001
25,44,766
2,43,099
10
-
9.6
0.004
-
0.003
-
10
2002
25,94,943
2,66,647
12
-
10.1
0.004
-
0.005
-
12
Source : District Malaria Officer, Coimbatore
National Surveillance Programme of Communicable Diseases Communicable disease surveillance is important to develop strategies for control and prevention of disease. It helps to forecast epidemics outbreak. The National Surveillance Programme of Communicable Diseases was started as a Pilot scheme in 1997. In Tamil Nadu, a National Surveillance Programme for Communicable Diseases has been launched in Dharmapuri, Villupuram, Coimbatore, Madurai and Salem.
The Zonal Entomological Team Zonal Entomological Teams attached to all the 72 Zones in the country Carry out Entomological Surveys & Surveillance
Common Tasks are, to find out 1) Which Anopheline Sps are present 2) Which of them are Vectors of Malaria 3) The biology & behaviour of adult vector mosquitoes’ nesting habits (in/outdoors), feeding habits, seasonal changes in the numbers biting humans, duration of adult life and the areas in which they are found 4) Breeding Habits of the Mosquitoes 5) Which Vectors are Susceptible (or) Resistant to Insecticides
Distribution of Pf % in India, 1986-97
Last Modified : 15 October, 2003 WHO Regional Office for South-East Asia
Chloroquine Resistance Status Of India,1997
Last Modified : 15 October, 2003 WHO Regional Office for South-East Asia
Dynamics of P.falciparum in India,1985-99
Last Modified : 15 October, 2003 WHO Regional Office for South-East Asia
Status of P.falciparum Resistance to Anti Malarial Drugs In India,1986-95
Last Modified : 15 October, 2003 WHO Regional Office for South-East Asia
Pf Resistance Status of Alternative Anti malarials in India,1997
Last Modified : 15 October, 2003 WHO Regional Office for South-East Asia
Proposed RBM Core Indicators I.IMPACT Crude death rate among target groups. Malaria death rate (probable and confirmed cases) among target groups. % of probable and confirmed malaria deaths among patients with severe malaria admitted to a health facility. Number of cases of severe malaria (probable and confirmed) among target groups. Number of cases of uncomplicated malaria (probable and confirmed) among target groups. Annual Parasite Incidence (API) among target groups (by region/according to the epidemiological situation). II.MALARIA PREVENTION AND DISEASE MANAGEMENT Prevention % of countries having introduced pyrethroids for public health use and insecticide-treated materials in the list of essential drugs and materials. % of service providers (health personnel, CHW…) trained in techniques of treatment of nets and/or indoor spraying according to the national policy. % of households having at least one treated bednet. % of pregnant women who have taken chemoprophylaxis or intermittent drug treatment, according to the national drug policy. % of antenatal clinic staff trained in preventive intermittent antimalarial treatment for pregnant women. Prevention and control of epidemics % of countries with epidemic prone areas/situation having a national preparedness plan of action for early detection and control of epidemics. % of malaria epidemics detected within two weeks of onset and properly controlled. Early diagnosis and Prompt Treatment % of health personnel involved in patient care trained in malaria case management and IMCI. % of health facilities able to confirm malaria diagnosis according to national policy (micro s c o py, rapid test etc.). % of patients hospitalised with a diagnosis of severe malaria and receiving correct antimalarial and supportive treatment according to the national guidelines. % of patients with uncomplicated malaria getting correct treatment at health facility and community levels according to national guidelines within 24 hrs of onset of symptoms.
III.HEALTH SECTOR DEVELOPMENT Health Policy % of districts with plans of action reflecting national health policy. % of districts using health information for planning. % of countries having a policy of universal coverage for all with a basic package including relevant malaria control activities. Service Delivery % of health facilities reporting no disruption of stock of antimalarial drugs, as specified in the national drug policy, for more than one week during the previous three months. Community Action % of countries having national guidelines for malaria prevention and treatment including training of all the informal health providers and recommendations for home treatment of febrile illness/suspected malaria, recognition of the most frequent signs of danger for children, prevention of malaria during pregnancy and use of insecticide treated materials. % of villages/communities with at least one Community Health Worker trained in management of fever and recognition of severe febrile illness. % of mothers/caretakers able to recognise signs and symptoms of danger of a febrile disease in a child < 5 years. IV. INTERSECTORAL LINKAGES % of countries with multisectoral and inter-agencies partnership established. % of countries having established official linkages, including the elaboration of research agenda of public health interest, between research institutions and Ministry of Health. V. SUPPORT/PARTNERSHIP % of countries with agreed national RBM budget met by donor funding. % of countries with functional sentinel sites for surveillance efficacy of 1st and 2nd line antimalarial drugs. Number of antimalarial drugs which have progressed to the level of phase III trials.
National Malaria Eradication Programme Programme Achievements $
+#
(
%
)
*
!
)
(
"## % &' #
!
(
)
"## $#
(
!
!
!
!
!
# !
#
!
!
!
!
!
PARASITOLOGICAL DIAGNOSIS- SMEAR
PARASITOLOGICAL DIAGNOSIS- SMEAR